Bluelinea Société Anonyme (ALBLU.PA)

EUR 0.85

(2.41%)

Total Debt Summary of Bluelinea Société Anonyme

  • Bluelinea Société Anonyme's latest annual total debt in 2022 was 3.61 Million EUR , down -9.25% from previous year.
  • Bluelinea Société Anonyme's latest quarterly total debt in 2024 Q2 was 4.52 Million EUR , down 0.0% from previous quarter.
  • Bluelinea Société Anonyme reported annual total debt of 3.98 Million EUR in 2021, up 32.61% from previous year.
  • Bluelinea Société Anonyme reported annual total debt of 3 Million EUR in 2020, up 194.43% from previous year.
  • Bluelinea Société Anonyme reported quarterly total debt of 3.62 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Bluelinea Société Anonyme reported quarterly total debt of 3.99 Million EUR for 2022 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of Bluelinea Société Anonyme (2022 - 2011)

Historical Annual Total Debt of Bluelinea Société Anonyme (2022 - 2011)

Year Total Debt Total Debt Growth
2022 3.61 Million EUR -9.25%
2021 3.98 Million EUR 32.61%
2020 3 Million EUR 194.43%
2019 1.02 Million EUR 129.98%
2018 444.18 Thousand EUR 8.21%
2017 410.47 Thousand EUR 39.11%
2016 295.07 Thousand EUR -48.88%
2015 577.16 Thousand EUR -16.56%
2014 691.75 Thousand EUR 1855.82%
2013 35.36 Thousand EUR 588.78%
2012 5135.00 EUR 0.0%
2011 - EUR 0.0%

Peer Total Debt Comparison of Bluelinea Société Anonyme

Name Total Debt Total Debt Difference
Affluent Medical SA 17.13 Million EUR 78.876%
Carmat SA 57.64 Million EUR 93.722%
Diagnostic Medical Systems S.A. 16.28 Million EUR 77.774%
Euromedis Groupe 10.01 Million EUR 63.868%
Eurobio Scientific Société anonyme 100.63 Million EUR 96.403%
Ikonisys S.A. 3.2 Million EUR -12.843%
Implanet S.A. 6.15 Million EUR 41.157%
Median Technologies SA 23.01 Million EUR 84.272%
SpineGuard SA 3.08 Million EUR -17.32%
Theraclion SA 1.95 Million EUR -85.543%
Euroapi S.A. 225.5 Million EUR 98.395%
Guerbet SA 383.87 Million EUR 99.057%
Ion Beam Applications SA 41.58 Million EUR 91.296%
Koninklijke Philips N.V. 7.68 Billion EUR 99.953%
Sequana Medical NV 16.78 Million EUR 78.439%